Sputnik V in India: Submit immunogenicity data, SEC tells Dr Reddy before nod for Russian vaccine
Sputnik V in India: Submit immunogenicity data, SEC tells Dr Reddy before nod for Russian vaccine Premium A Venezuelan health worker prepares a syringe with Russia's Sputnik V vaccine against the coronavirus disease (COVID-19), at a hospital, in Caracas, Venezuela February 22, 2021. REUTERS/Leonardo Fernandez Viloria NO RESALES. NO ARCHIVES (REUTERS) Share Via Read Full Story The Subject Expert Committee (SEC) of the Indian drug regulator on Wednesday took up an application by pharma giant Dr Reddy's Laboratories seeking emergency approval for Sputnik V, the Russia-developed Covid-19 vaccine...
Source: livemint.com